Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan

BACKGROUND: Currently in Japan, both 23-valent pneumococcal polysaccharide vaccine (PPSV–23) and 13-valent pneumococcal conjugate vaccine (PCV–13) are available for the elderly for the prevention of S. pneumoniae-related diseases. PPSV–23 was approved in 1988, while the extended use of PCV–13 was ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshi, Shu-ling, Kondo, Masahide, Okubo, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596483/
https://www.ncbi.nlm.nih.gov/pubmed/26444287
http://dx.doi.org/10.1371/journal.pone.0139140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596483/
https://www.ncbi.nlm.nih.gov/pubmed/26444287
http://dx.doi.org/10.1371/journal.pone.0139140

Ejemplares similares